CN Stock MarketDetailed Quotes

300558 Betta Pharmaceuticals

Watchlist
  • 55.35
  • +2.66+5.05%
Market Closed Nov 29 15:00 CST
23.16BMarket Cap50.41P/E (TTM)

Betta Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
14.73%2.34B
14.22%1.5B
38.40%735.78M
3.35%2.46B
22.90%2.04B
4.83%1.31B
-9.08%531.62M
5.82%2.38B
-3.58%1.66B
8.50%1.25B
Operating revenue
14.73%2.34B
14.22%1.5B
38.40%735.78M
3.35%2.46B
22.90%2.04B
4.83%1.31B
-9.08%531.62M
5.82%2.38B
-3.58%1.66B
8.50%1.25B
Other operating revenue
----
-26.39%14.29M
----
15.30%39.41M
----
12.32%19.41M
----
-14.65%34.18M
----
-13.61%17.28M
Total operating cost
9.59%1.98B
2.53%1.26B
20.78%641.56M
-7.60%2.21B
12.16%1.81B
1.22%1.23B
6.49%531.2M
26.21%2.4B
17.62%1.61B
32.13%1.22B
Operating cost
29.44%379.68M
16.69%242.27M
64.26%128.54M
50.54%404.48M
54.43%293.32M
49.61%207.62M
11.10%78.26M
54.04%268.69M
52.54%189.93M
64.63%138.77M
Operating tax surcharges
8.50%14.98M
8.18%9.86M
31.55%5.11M
-19.76%14.07M
21.87%13.81M
20.44%9.11M
-14.95%3.89M
15.42%17.53M
20.18%11.33M
29.64%7.56M
Operating expense
22.70%870.56M
14.37%523.71M
49.54%230.48M
9.61%853.89M
44.74%709.52M
3.99%457.91M
-14.68%154.12M
-4.38%779.06M
-26.30%490.18M
-1.10%440.33M
Administration expense
0.77%294.43M
3.67%211.13M
12.68%114.73M
-42.49%261.76M
-31.91%292.17M
-34.17%203.65M
-23.49%101.82M
39.28%455.16M
109.40%429.06M
116.90%309.35M
Financial expense
21.83%34.55M
3.92%18.13M
-43.99%9.95M
-77.45%39.59M
304.65%28.36M
658.59%17.44M
616.74%17.76M
14,357.73%175.57M
696.78%7.01M
369.83%2.3M
-Interest expense (Financial expense)
-25.22%31.55M
-25.75%22.28M
-43.59%11.01M
-71.93%54.95M
70.71%42.19M
115.58%30M
368.75%19.51M
1,140.90%195.8M
107.02%24.71M
75.65%13.92M
-Interest Income (Financial expense)
30.03%-5.13M
21.27%-3.96M
22.05%-2.64M
5.95%-10.23M
2.47%-7.33M
0.76%-5.03M
-29.09%-3.39M
40.84%-10.88M
42.66%-7.52M
46.37%-5.07M
Research and development
-17.93%384.04M
-23.39%256.28M
-12.89%152.75M
-8.54%640.14M
-2.90%467.94M
5.50%334.52M
62.91%175.36M
23.67%699.9M
31.84%481.92M
30.65%317.07M
Credit Impairment Loss
186.52%6.83M
380.40%6.82M
232.75%5.07M
-252.67%-8.8M
-5.59%-7.89M
46.85%-2.43M
-2,102.40%-3.82M
-292.30%-2.5M
-1,177.59%-7.48M
-9,504.39%-4.58M
Asset Impairment Loss
----
----
----
----
----
----
----
---3.52M
----
----
Other net revenue
5,148.18%71.86M
415.35%14.49M
218.01%14.15M
-75.64%27.79M
-103.50%-1.42M
-92.49%2.81M
-60.21%4.45M
137.46%114.09M
48.82%40.7M
61.42%37.44M
Fair value change income
--46.81M
----
----
68.91%-312.61K
----
----
----
-200.00%-1.01M
---1.01M
-143.44%-1.01M
Invest income
55.67%-6.51M
50.07%-5.18M
-76.11%-2.15M
31.90%-13.36M
-3,550.74%-14.68M
-5,844.18%-10.38M
-217.84%-1.22M
-231.12%-19.61M
-103.58%-402.06K
-97.23%180.74K
-Including: Investment income associates
53.03%-6.89M
50.07%-5.18M
-76.11%-2.15M
33.79%-13.99M
-675.60%-14.68M
-692.73%-10.38M
-169.51%-1.22M
-4,072.95%-21.12M
---1.89M
---1.31M
Asset deal income
111.77%121.27K
-1,722.04%-6.19M
-14,919.64%-1.77M
-100.01%-10.73K
-1,041.05%-1.03M
-267.06%-339.65K
83.26%-11.79K
130,084.94%88.61M
4.61%109.45K
89.60%203.31K
Other revenue
10.97%24.61M
19.28%19.04M
36.73%13M
-3.53%50.27M
-55.17%22.18M
-62.55%15.97M
-16.57%9.5M
59.61%52.11M
198.28%49.47M
198.47%42.64M
Operating profit
84.91%438.27M
193.72%253.89M
2,128.02%108.36M
184.89%270.07M
152.17%237.02M
14.66%86.44M
-94.99%4.86M
-76.04%94.8M
-75.49%93.99M
-70.84%75.39M
Add:Non operating Income
-99.65%211.67K
-99.64%215.27K
----
2,629.24%61.58M
2,141.33%59.8M
2,834.84%59.78M
5,334.45%33.39M
-16.44%2.26M
0.90%2.67M
-20.78%2.04M
Less:Non operating expense
32.26%6.66M
0.19%4.02M
-58.83%1.13M
1.00%9.58M
-22.77%5.04M
-24.04%4.02M
48.99%2.75M
13.25%9.48M
-8.02%6.52M
-5.71%5.29M
Total profit
47.99%431.82M
75.86%250.08M
202.02%107.23M
267.79%322.07M
223.70%291.78M
97.13%142.21M
-62.94%35.5M
-77.54%87.57M
-76.22%90.14M
-71.77%72.14M
Less:Income tax cost
1,240.95%26.67M
5,293.30%33.96M
208.03%13.44M
68.97%-11.54M
-272.67%-2.34M
104.46%629.65K
-175.22%-12.44M
-458.76%-37.19M
-96.28%1.35M
-132.68%-14.11M
Net profit
37.75%405.15M
52.65%216.12M
95.64%93.79M
167.40%333.62M
231.27%294.12M
64.14%141.58M
-39.52%47.94M
-67.13%124.76M
-74.09%88.79M
-59.38%86.25M
Net profit from continuing operation
37.75%405.15M
52.65%216.12M
95.64%93.79M
167.40%333.62M
231.27%294.12M
64.14%141.58M
-39.52%47.94M
-67.13%124.76M
-74.09%88.79M
-59.38%86.25M
Less:Minority Profit
-4.74%-11.07M
-16.27%-7.82M
-25.89%-4.35M
30.21%-14.42M
24.61%-10.57M
20.50%-6.73M
21.58%-3.46M
-489.00%-20.66M
-236.77%-14.02M
-205.78%-8.46M
Net profit of parent company owners
36.61%416.23M
51.00%223.95M
90.95%98.14M
139.33%348.03M
196.38%304.69M
56.58%148.31M
-38.58%51.4M
-62.04%145.42M
-70.36%102.81M
-55.96%94.72M
Earning per share
Basic earning per share
35.62%0.99
50.00%0.54
91.67%0.23
137.14%0.83
192.00%0.73
56.52%0.36
-40.00%0.12
-61.96%0.35
-70.24%0.25
-55.77%0.23
Diluted earning per share
35.62%0.99
54.29%0.54
91.67%0.23
137.14%0.83
192.00%0.73
52.17%0.35
-40.00%0.12
-61.96%0.35
-69.51%0.25
-55.77%0.23
Other composite income
-481.19%-32.15M
-57.10%14.55M
507.29%147.49M
14.85%60.76M
-83.45%8.43M
2,169.06%33.93M
-35.76%-36.21M
127.40%52.9M
-33.45%50.94M
-98.20%1.5M
Other composite income of parent company owners
-481.19%-32.15M
-57.10%14.55M
507.29%147.49M
14.85%60.76M
-83.45%8.43M
2,169.06%33.93M
-35.76%-36.21M
127.40%52.9M
-33.45%50.94M
-98.20%1.5M
Total composite income
23.29%373.01M
31.44%230.68M
1,957.23%241.28M
121.98%394.37M
116.53%302.56M
100.01%175.5M
-77.70%11.73M
-55.90%177.66M
-66.67%139.73M
-70.29%87.75M
Total composite income of parent company owners
22.66%384.08M
30.88%238.5M
1,517.73%245.63M
106.12%408.79M
103.66%313.13M
89.41%182.23M
-73.36%15.18M
-51.19%198.32M
-63.69%153.75M
-67.73%96.21M
Total composite income of minority owners
-4.74%-11.07M
-16.27%-7.82M
-25.89%-4.35M
30.21%-14.42M
24.61%-10.57M
20.50%-6.73M
21.58%-3.46M
-489.00%-20.66M
-236.77%-14.02M
-205.78%-8.46M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 14.73%2.34B14.22%1.5B38.40%735.78M3.35%2.46B22.90%2.04B4.83%1.31B-9.08%531.62M5.82%2.38B-3.58%1.66B8.50%1.25B
Operating revenue 14.73%2.34B14.22%1.5B38.40%735.78M3.35%2.46B22.90%2.04B4.83%1.31B-9.08%531.62M5.82%2.38B-3.58%1.66B8.50%1.25B
Other operating revenue -----26.39%14.29M----15.30%39.41M----12.32%19.41M-----14.65%34.18M-----13.61%17.28M
Total operating cost 9.59%1.98B2.53%1.26B20.78%641.56M-7.60%2.21B12.16%1.81B1.22%1.23B6.49%531.2M26.21%2.4B17.62%1.61B32.13%1.22B
Operating cost 29.44%379.68M16.69%242.27M64.26%128.54M50.54%404.48M54.43%293.32M49.61%207.62M11.10%78.26M54.04%268.69M52.54%189.93M64.63%138.77M
Operating tax surcharges 8.50%14.98M8.18%9.86M31.55%5.11M-19.76%14.07M21.87%13.81M20.44%9.11M-14.95%3.89M15.42%17.53M20.18%11.33M29.64%7.56M
Operating expense 22.70%870.56M14.37%523.71M49.54%230.48M9.61%853.89M44.74%709.52M3.99%457.91M-14.68%154.12M-4.38%779.06M-26.30%490.18M-1.10%440.33M
Administration expense 0.77%294.43M3.67%211.13M12.68%114.73M-42.49%261.76M-31.91%292.17M-34.17%203.65M-23.49%101.82M39.28%455.16M109.40%429.06M116.90%309.35M
Financial expense 21.83%34.55M3.92%18.13M-43.99%9.95M-77.45%39.59M304.65%28.36M658.59%17.44M616.74%17.76M14,357.73%175.57M696.78%7.01M369.83%2.3M
-Interest expense (Financial expense) -25.22%31.55M-25.75%22.28M-43.59%11.01M-71.93%54.95M70.71%42.19M115.58%30M368.75%19.51M1,140.90%195.8M107.02%24.71M75.65%13.92M
-Interest Income (Financial expense) 30.03%-5.13M21.27%-3.96M22.05%-2.64M5.95%-10.23M2.47%-7.33M0.76%-5.03M-29.09%-3.39M40.84%-10.88M42.66%-7.52M46.37%-5.07M
Research and development -17.93%384.04M-23.39%256.28M-12.89%152.75M-8.54%640.14M-2.90%467.94M5.50%334.52M62.91%175.36M23.67%699.9M31.84%481.92M30.65%317.07M
Credit Impairment Loss 186.52%6.83M380.40%6.82M232.75%5.07M-252.67%-8.8M-5.59%-7.89M46.85%-2.43M-2,102.40%-3.82M-292.30%-2.5M-1,177.59%-7.48M-9,504.39%-4.58M
Asset Impairment Loss -------------------------------3.52M--------
Other net revenue 5,148.18%71.86M415.35%14.49M218.01%14.15M-75.64%27.79M-103.50%-1.42M-92.49%2.81M-60.21%4.45M137.46%114.09M48.82%40.7M61.42%37.44M
Fair value change income --46.81M--------68.91%-312.61K-------------200.00%-1.01M---1.01M-143.44%-1.01M
Invest income 55.67%-6.51M50.07%-5.18M-76.11%-2.15M31.90%-13.36M-3,550.74%-14.68M-5,844.18%-10.38M-217.84%-1.22M-231.12%-19.61M-103.58%-402.06K-97.23%180.74K
-Including: Investment income associates 53.03%-6.89M50.07%-5.18M-76.11%-2.15M33.79%-13.99M-675.60%-14.68M-692.73%-10.38M-169.51%-1.22M-4,072.95%-21.12M---1.89M---1.31M
Asset deal income 111.77%121.27K-1,722.04%-6.19M-14,919.64%-1.77M-100.01%-10.73K-1,041.05%-1.03M-267.06%-339.65K83.26%-11.79K130,084.94%88.61M4.61%109.45K89.60%203.31K
Other revenue 10.97%24.61M19.28%19.04M36.73%13M-3.53%50.27M-55.17%22.18M-62.55%15.97M-16.57%9.5M59.61%52.11M198.28%49.47M198.47%42.64M
Operating profit 84.91%438.27M193.72%253.89M2,128.02%108.36M184.89%270.07M152.17%237.02M14.66%86.44M-94.99%4.86M-76.04%94.8M-75.49%93.99M-70.84%75.39M
Add:Non operating Income -99.65%211.67K-99.64%215.27K----2,629.24%61.58M2,141.33%59.8M2,834.84%59.78M5,334.45%33.39M-16.44%2.26M0.90%2.67M-20.78%2.04M
Less:Non operating expense 32.26%6.66M0.19%4.02M-58.83%1.13M1.00%9.58M-22.77%5.04M-24.04%4.02M48.99%2.75M13.25%9.48M-8.02%6.52M-5.71%5.29M
Total profit 47.99%431.82M75.86%250.08M202.02%107.23M267.79%322.07M223.70%291.78M97.13%142.21M-62.94%35.5M-77.54%87.57M-76.22%90.14M-71.77%72.14M
Less:Income tax cost 1,240.95%26.67M5,293.30%33.96M208.03%13.44M68.97%-11.54M-272.67%-2.34M104.46%629.65K-175.22%-12.44M-458.76%-37.19M-96.28%1.35M-132.68%-14.11M
Net profit 37.75%405.15M52.65%216.12M95.64%93.79M167.40%333.62M231.27%294.12M64.14%141.58M-39.52%47.94M-67.13%124.76M-74.09%88.79M-59.38%86.25M
Net profit from continuing operation 37.75%405.15M52.65%216.12M95.64%93.79M167.40%333.62M231.27%294.12M64.14%141.58M-39.52%47.94M-67.13%124.76M-74.09%88.79M-59.38%86.25M
Less:Minority Profit -4.74%-11.07M-16.27%-7.82M-25.89%-4.35M30.21%-14.42M24.61%-10.57M20.50%-6.73M21.58%-3.46M-489.00%-20.66M-236.77%-14.02M-205.78%-8.46M
Net profit of parent company owners 36.61%416.23M51.00%223.95M90.95%98.14M139.33%348.03M196.38%304.69M56.58%148.31M-38.58%51.4M-62.04%145.42M-70.36%102.81M-55.96%94.72M
Earning per share
Basic earning per share 35.62%0.9950.00%0.5491.67%0.23137.14%0.83192.00%0.7356.52%0.36-40.00%0.12-61.96%0.35-70.24%0.25-55.77%0.23
Diluted earning per share 35.62%0.9954.29%0.5491.67%0.23137.14%0.83192.00%0.7352.17%0.35-40.00%0.12-61.96%0.35-69.51%0.25-55.77%0.23
Other composite income -481.19%-32.15M-57.10%14.55M507.29%147.49M14.85%60.76M-83.45%8.43M2,169.06%33.93M-35.76%-36.21M127.40%52.9M-33.45%50.94M-98.20%1.5M
Other composite income of parent company owners -481.19%-32.15M-57.10%14.55M507.29%147.49M14.85%60.76M-83.45%8.43M2,169.06%33.93M-35.76%-36.21M127.40%52.9M-33.45%50.94M-98.20%1.5M
Total composite income 23.29%373.01M31.44%230.68M1,957.23%241.28M121.98%394.37M116.53%302.56M100.01%175.5M-77.70%11.73M-55.90%177.66M-66.67%139.73M-70.29%87.75M
Total composite income of parent company owners 22.66%384.08M30.88%238.5M1,517.73%245.63M106.12%408.79M103.66%313.13M89.41%182.23M-73.36%15.18M-51.19%198.32M-63.69%153.75M-67.73%96.21M
Total composite income of minority owners -4.74%-11.07M-16.27%-7.82M-25.89%-4.35M30.21%-14.42M24.61%-10.57M20.50%-6.73M21.58%-3.46M-489.00%-20.66M-236.77%-14.02M-205.78%-8.46M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data